| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6555581 | KING PHARMS | Levothyroxine compositions and methods |
Feb, 2022
(2 years ago) | |
| US7067148 | KING PHARMS | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
Feb, 2022
(2 years ago) | |
| US7101569 | KING PHARMS | Methods of administering levothyroxine pharmaceutical compositions |
Oct, 2023
(6 months ago) | |
Levoxyl is owned by King Pharms.
Levoxyl contains Levothyroxine Sodium.
Levoxyl has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Levoxyl are:
- US6555581
- US7067148
- US7101569
Levoxyl was authorised for market use on 25 May, 2001.
Levoxyl is available in tablet;oral dosage forms.
Levoxyl can be used as method of use of administering levothyroxine.
The generics of Levoxyl are possible to be released after 02 October, 2023.
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 25 May, 2001
Treatment: Method of use of administering levothyroxine
Dosage: TABLET;ORAL
How can I launch a generic of LEVOXYL before it's drug patent expiration?
More Information on Dosage
LEVOXYL family patents
